Compare SIBN & OMDA Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | SIBN | OMDA |
|---|---|---|
| Founded | 2008 | 2011 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Medical/Dental Instruments | Medical/Nursing Services |
| Sector | Health Care | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 886.9M | 897.6M |
| IPO Year | 2018 | N/A |
| Metric | SIBN | OMDA |
|---|---|---|
| Price | $15.48 | $11.62 |
| Analyst Decision | Strong Buy | Buy |
| Analyst Count | 8 | 10 |
| Target Price | ★ $25.00 | $24.80 |
| AVG Volume (30 Days) | 415.2K | ★ 1.1M |
| Earning Date | 04-01-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ 33.63 | N/A |
| EPS | N/A | ★ N/A |
| Revenue | ★ $67,301,000.00 | N/A |
| Revenue This Year | $21.95 | $52.49 |
| Revenue Next Year | $15.02 | $22.68 |
| P/E Ratio | ★ N/A | N/A |
| Revenue Growth | ★ 21.53 | N/A |
| 52 Week Low | $12.50 | $10.28 |
| 52 Week High | $21.89 | $26.92 |
| Indicator | SIBN | OMDA |
|---|---|---|
| Relative Strength Index (RSI) | 37.57 | 33.83 |
| Support Level | $15.11 | $10.99 |
| Resistance Level | $15.92 | $12.05 |
| Average True Range (ATR) | 0.55 | 0.98 |
| MACD | 0.09 | -0.00 |
| Stochastic Oscillator | 39.10 | 32.29 |
SI-BONE Inc is a medical device company, that develops and commercializes a proprietary minimally invasive surgical implant system in the United States and Internationally. Its products include a series of patented titanium implants and the instruments used to implant them, as well as implantable bone products such as iFuse-3D, iFuse-TORQ and iFuse Bedrock Granite which have applications across sacroiliac joint dysfunction and fusion, adult spinal deformity and degeneration, and pelvic trauma.
Omada Health Inc empowers individuals to make lasting health changes through personalized, virtual care between doctor's visits. The integrated platform of the company supports members with cardiometabolic conditions like prediabetes, diabetes, hypertension, musculoskeletal issues, and behavioral health needs. The company's specialized care tracks also assist members using GLP-1 medications. The Company delivers measurable health outcomes and value for employers, health plans, health systems, and pharmacy benefit managers.